1. Human molybdenum exposure risk in industrial regions of China: New critical effect indicators and reference dose.
- Author
-
Kuang, Hong-Xuan, Li, Meng-Yang, Zeng, Xiao-Wen, Chen, Da, Zhou, Yang, Zheng, Tong, Xiang, Ming-Deng, Wu, Qi-Zhen, Chen, Xi-Chao, Dong, Guang-Hui, and Yu, Yun-Jiang
- Subjects
MOLYBDENUM ,LUNGS ,RISK exposure ,CHRONIC kidney failure ,GLOMERULAR filtration rate ,CYSTATIN C ,ENVIRONMENTAL exposure - Abstract
Evidence increasingly suggests molybdenum exposure at environmental levels is still associated with adverse human health, emphasizing the necessity to establish a more protective reference dose (RfD). Herein, we conducted a study measuring 15 urinary metals and 30 clinical health indicators in 2267 participants residing near chemical enterprises across 11 Chinese provinces to investigate their relationships. The kidney and cystatin-C emerged as the most sensitive organ and critical effect indicator of molybdenum exposure, respectively. Odds of cystatin-C-defined chronic kidney disease (CKD) in the highest quantile of molybdenum exposure significantly increased by 133.5% (odds ratio [OR]: 2.34, 95% CI: 1.78, 3.11) and 75.8% (OR: 1.76, 95% CI: 1.24, 2.49) before and after adjusting for urinary 14 metals, respectively. Intriguingly, cystatin-C significantly mediated 15.9–89.5% of molybdenum's impacts on liver and lung function, suggesting nephrotoxicity from molybdenum exposure may trigger hepatotoxicity and pulmonary toxicity. We derived a new RfD for molybdenum exposure (0.87 μg/kg-day) based on cystatin-C-defined estimated glomerular filtration rate by employing Bayesian Benchmark Dose modeling analysis. This RfD is significantly lower than current exposure guidance values (5–30 μg/kg-day). Remarkably, >90% of participants exceeded the new RfD, underscoring the significant health impacts of environmental molybdenum exposure on populations in industrial regions of China. [Display omitted] • CYS-C was first identified as the critical effect indicator of Mo exposure. • CYS-C mediated 15.9–89.5% of molybdenum's impacts on liver and lung function. • Elevated Sr markedly attenuated the nephrotoxicity associated with Mo exposure. • The new RfD (0.87 μg/kg-day) was far lower than the current intake guidance values. • >90% participants faced non-carcinogenic risk from Mo exposure using the new RfD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF